Dr. Petersen’s journey with Shockwave technology began in 2000, when he was introduced to the original Ossatron system, becoming one of the first physicians in the United States to utilize this groundbreaking technology for musculoskeletal conditions.
At the time, treatments were performed in the operating room under IV sedation, primarily targeting chronic plantar fasciitis and Achilles tendinitis. Over a ten-year period, Dr. Petersen and his group treated approximately 400 patients with remarkable success:
“Even early on, we were seeing results that we simply could not achieve with traditional conservative care,” Dr. Petersen recalls. Beyond treating patients, Dr. Petersen also played a key role in training more than 150 physicians and podiatrists, helping expand the awareness and the adoption of Shockwave technology across the United States.
Dr. Petersen’s practice serves a highly active demographic:
Common conditions treated include:
Many patients present with chronic pain and inconclusive imaging, making Shockwave a valuable diagnostic and therapeutic tool that Dr. Petersen often refers to as a “pain finder.”
When these approaches failed after 6–12 months, surgery often became the only remaining option. “Patients would spend a year or more trying everything, only to end up facing surgery,” says Dr. Petersen. “We needed something better. Something that could actually stimulate healing.”
After stepping away from Shockwave for several years as the technology evolved, Dr. Petersen re-entered the space with renewed enthusiasm:
This combination of Shockwave Technology and EMTT has transformed his practice. EPAT allows him to address broad soft tissue conditions, while focused ESWT delivers precision treatment for deeper, more chronic pathologies. EMTT complements both by working at the cellular level to prime tissue for healing and accelerate recovery.
Dr. Petersen has experienced firsthand how these technologies work together. After suffering from chronic thumb pain following a basketball injury, he was treated with focused Shockwave and saw complete resolution within weeks. Later, he treated his own chronic sacroiliac (SI) joint pain using EMTT:
“EMTT helps reset the cellular environment,” he explains. “It takes tissue that’s inflamed and stagnant, and allows it to function normally again, making everything else we do more effective.”
Integrating Shockwave and EMTT has not only improved patient outcomes, but it has also significantly increased practice profitability.
While initially hesitant about cash-pay models, Dr. Petersen found that patient education eliminates most resistance. “When patients understand the value, and more importantly, when they see results, there’s very little pushback.” Word-of-mouth referrals, combined with visibility on digital platforms, and within active communities like pickleball, have fueled consistent growth.
Dr. Petersen encourages other providers to take the next step:
“Treat yourself, treat your staff—see what it does. There’s no better way to understand its value.” His message is clear: “Don’t hesitate. This technology changes practices, and it changes patients’ lives.”
For Dr. Petersen, choosing CuraMedix and STORZ Medical was an easy decision.
“CuraMedix treats you like family. If there’s ever an issue, the response is immediate. That level of support makes all the difference.”
Ready to join Dr. Petersen, and offer next-level care for your own patients? Contact us today to connect with one of our experts and revolutionize your practice.
Important to Note: The treatments and use of EPAT®, ESWT, and EMTT® described in this article reflect the personal clinical experience of the practitioner and are not intended as claims of efficacy.